What is the share price of Shamrock Industrial Company Ltd (SHAMROIN) today?
The share price of SHAMROIN as on 11th March 2025 is ₹13. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Shamrock Industrial Company Ltd (SHAMROIN) share?
The past returns of Shamrock Industrial Company Ltd (SHAMROIN) share are- Past 1 week: -11.16%
- Past 1 month: -18.90%
- Past 3 months: 13.34%
- Past 6 months: 20.48%
- Past 1 year: 21.38%
- Past 3 years: 69.05%
- Past 5 years: 140.30%
What are the peers or stocks similar to Shamrock Industrial Company Ltd (SHAMROIN)?
The peers or stocks similar to Shamrock Industrial Company Ltd (SHAMROIN) include:What is the market cap of Shamrock Industrial Company Ltd (SHAMROIN) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shamrock Industrial Company Ltd (SHAMROIN) is ₹7.06 Cr as of 11th March 2025.What is the 52 week high and low of Shamrock Industrial Company Ltd (SHAMROIN) share?
The 52-week high of Shamrock Industrial Company Ltd (SHAMROIN) is ₹17.73 and the 52-week low is ₹7.22.What is the PE and PB ratio of Shamrock Industrial Company Ltd (SHAMROIN) stock?
The P/E (price-to-earnings) ratio of Shamrock Industrial Company Ltd (SHAMROIN) is -176.42. The P/B (price-to-book) ratio is 4.08.Which sector does Shamrock Industrial Company Ltd (SHAMROIN) belong to?
Shamrock Industrial Company Ltd (SHAMROIN) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Shamrock Industrial Company Ltd (SHAMROIN) shares?
You can directly buy Shamrock Industrial Company Ltd (SHAMROIN) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Shamrock Industrial Company Ltd
SHAMROINShamrock Industrial Company Ltd
SHAMROIN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7 cr, stock is ranked 4,624
High RiskStock is 3.14x as volatile as Nifty
13.000.00% (+0.00)
13.000.00% (+0.00)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -58.81 | 4.08 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.89 | 5.97 | 0.56% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Shamrock Industrial Company Limited (SICL) is engaged in the field of pharmaceutical raw materials, intermediates and fine chemicals. The Company offers its products to active pharmaceutical ingredient (API) manufacturers, labs, etc
Peers
Compare with peersSUNPHARMA
PE Ratio
40.38
1Y Return
1.12%
Buy Reco %
85.29
CIPLA
PE Ratio
28.66
1Y Return
2.75%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
62.75
1Y Return
13.84%
Buy Reco %
68.00
DRREDDY
PE Ratio
16.73
1Y Return
12.31%
Buy Reco %
45.16
MANKIND
PE Ratio
48.73
1Y Return
4.48%
Buy Reco %
80.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.54 | 0.00 | 0.03 | 6.45 | 0.00 | 0.01 | 0.10 | 0.00 | 0.11 | — | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 0.00 | 0.00 | 0.02 | 0.14 | 0.04 | 0.01 | 0.02 | 0.02 | 0.02 | |||||||||||
| Selling & Administrative Expenses | 0.09 | 0.03 | 0.07 | 3.51 | 0.17 | 0.31 | 0.28 | 0.11 | 0.13 | |||||||||||
| Operating & Other expenses | 3.34 | 0.03 | 0.01 | 3.09 | 0.01 | 0.00 | -0.00 | 0.00 | 0.00 | |||||||||||
EBITDA | -1.89 | -0.06 | -0.07 | -0.29 | -0.22 | -0.31 | -0.20 | -0.13 | -0.04 | -0.12 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBIT | -1.89 | -0.06 | -0.07 | -0.29 | -0.22 | -0.31 | -0.20 | -0.13 | -0.04 | -0.12 | ||||||||||
| Interest & Other Items | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBT | -2.05 | -0.06 | -0.07 | -0.29 | -0.22 | -0.31 | -0.20 | -0.13 | -0.04 | -0.12 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -2.05 | -0.06 | -0.07 | -0.29 | -0.22 | -0.31 | -0.20 | -0.13 | -0.04 | -0.12 | ||||||||||
| EPS | -3.78 | -0.11 | -0.13 | -0.53 | -0.41 | -0.57 | -0.37 | -0.24 | -0.07 | -0.22 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
FY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFPeers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Shamrock Industrial Company Ltd | -176.42 | 4.08 | — |
| Sun Pharmaceutical Industries Ltd | 40.38 | 5.76 | 0.84% |
| Cipla Ltd | 28.66 | 4.41 | 0.89% |
| Torrent Pharmaceuticals Ltd | 62.75 | 15.16 | 0.91% |
Price Comparison
Compare SHAMROIN with any stock or ETFCompare SHAMROIN with any stock or ETF
SHAMROIN
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SHAMROIN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Earnings
Shamrock Industrial Co reports standalone net loss of Rs 0.02 crore in the December 2024 quarter
Net Loss of Shamrock Industrial Co reported to Rs 0.02 crore in the quarter ended December 2024 as against net loss of Rs 0.05 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Shamrock Industrial Company to table results
Shamrock Industrial Company will hold a meeting of the Board of Directors of the Company on 30 January 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Shamrock Industrial Co reports standalone net loss of Rs 0.02 crore in the September 2024 quarter
Net loss of Shamrock Industrial Co reported to Rs 0.02 crore in the quarter ended September 2024 as against net profit of Rs 0.09 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 as against Rs 0.11 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales00.11 -100 OPM %081.82 - PBDT-0.020.09 PL PBT-0.020.09 PL NP-0.020.09 PL Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Shamrock Industrial Company to conduct board meeting
Shamrock Industrial Company will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Shamrock Industrial Company to convene AGM
Shamrock Industrial Company announced that the 33th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Shamrock Industrial Co reports standalone net loss of Rs 0.06 crore in the June 2024 quarter
Net Loss of Shamrock Industrial Co reported to Rs 0.06 crore in the quarter ended June 2024 as against net loss of Rs 0.06 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Shamrock Industrial Company to conduct board meeting
Shamrock Industrial Company will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -55.7%, vs industry avg of 9.04%
Constant Market Share
Over the last 5 years, market share stayed at 0%